当前位置: X-MOL 学术Neuropharmacology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hyperactive Akt-mTOR pathway as a therapeutic target for pain hypersensitivity in Cntnap2-deficient mice.
Neuropharmacology ( IF 4.6 ) Pub Date : 2019-12-23 , DOI: 10.1016/j.neuropharm.2019.107816
Xiaoliang Xing 1 , Kunyang Wu 2 , Yufan Dong 2 , Yimei Zhou 3 , Jing Zhang 2 , Fang Jiang 2 , Wang-Ping Hu 3 , Jia-Da Li 2
Affiliation  

Contactin-associated protein-like 2 (CNTNAP2 or CASPR2) is a neuronal transmembrane protein of the neurexin superfamily that is involved in many neurological diseases, such as autism and pain hypersensitivity. We recently found that Cntnap2-/- mice showed elevated Akt-mTOR activity in the brain, and suppression of the Akt-mTOR pathway rescued the social deficit in Cntnap2-/- mice. In this study, we found that the dorsal root ganglion (DRG) from Cntnap2-/- mice also showed hyperactive Akt-mTOR signaling. Treatment with the Akt inhibitor LY94002 or the mTOR inhibitor rapamycin attenuated pain-related hypersensitivity to noxious mechanical stimuli, heat, and inflammatory substances. Further, suppression of mTOR signaling by rapamycin decreased DRG neuronal hyperexcitability. We further indicated that treatment with the FDA-approved drug metformin normalized the hyperactive Akt-mTOR signaling, and attenuated pain-related hypersensitivity in Cntnap2-/- mice. Our results thus identified hyperactive Akt-mTOR signaling pathway as a promising therapeutic target for pain-related hypersensitivity in patients with dysfunction of CNTNAP2.

中文翻译:

过度活跃的Akt-mTOR通路可作为Cntnap2缺陷小鼠疼痛超敏反应的治疗靶标。

接触蛋白相关蛋白样2(CNTNAP2或CASPR2)是神经毒素超家族的神经元跨膜蛋白,与许多神经系统疾病有关,例如自闭症和疼痛超敏反应。我们最近发现,Cntnap2-/-小鼠在大脑中显示出升高的Akt-mTOR活性,并且抑制Akt-mTOR途径可以挽救Cntnap2-/-小鼠的社交缺陷。在这项研究中,我们发现来自Cntnap2-/-小鼠的背根神经节(DRG)也显示过活跃的Akt-mTOR信号传导。用Akt抑制剂LY94002或mTOR抑制剂雷帕霉素治疗可减轻与疼痛有关的对有害机械刺激,热和炎性物质的超敏反应。此外,雷帕霉素对mTOR信号的抑制作用降低了DRG神经元的过度兴奋性。我们进一步表明,用FDA批准的药物二甲双胍治疗可使Ant-mTOR信号亢进正常化,并减轻Cntnap2-/-小鼠疼痛相关的超敏反应。因此,我们的结果确定了过度活跃的Akt-mTOR信号通路是CNTNAP2功能障碍患者疼痛相关超敏反应的有希望的治疗靶标。
更新日期:2019-12-23
down
wechat
bug